96 related articles for article (PubMed ID: 1980266)
1. Dose related protective effect of azelastine on histamine induced bronchoconstriction in extrinsic asthma.
Bauer K; Aurich R; Kaik G
Int J Clin Pharmacol Ther Toxicol; 1990 Aug; 28(8):333-8. PubMed ID: 1980266
[TBL] [Abstract][Full Text] [Related]
2. [Azelastine inhibits bronchoconstriction induced by histamine and leukotriene C4].
Tomooka M; Miyazaki N; Aizawa H; Shigematsu N; Ejima T
Arerugi; 1988 Apr; 37(4):213-7. PubMed ID: 2906534
[No Abstract] [Full Text] [Related]
3. Duration of the effect of a single dose of azelastine on histamine-induced bronchoconstriction.
Magnussen H; Reuss G; Jörres R; Aurich R
J Allergy Clin Immunol; 1989 Feb; 83(2 Pt 1):467-71. PubMed ID: 2563744
[TBL] [Abstract][Full Text] [Related]
4. Effect of azelastine on bronchoconstriction induced by histamine and leukotriene C4 in patients with extrinsic asthma.
Albazzaz MK; Patel KR
Thorax; 1988 Apr; 43(4):306-11. PubMed ID: 2900560
[TBL] [Abstract][Full Text] [Related]
5. The inhibitory effect of azelastine and ketotifen on histamine-induced bronchoconstriction in asthmatic patients.
Magnussen H
Chest; 1987 Jun; 91(6):855-8. PubMed ID: 2884081
[TBL] [Abstract][Full Text] [Related]
6. The inhibitory effect of azelastine hydrochloride on histamine- and allergen-induced bronchoconstriction in atopic asthma.
Rafferty P; Holgate ST
Clin Exp Allergy; 1989 May; 19(3):315-20. PubMed ID: 2736431
[TBL] [Abstract][Full Text] [Related]
7. Topical azelastine has a 12-hour duration of action as assessed by histamine challenge-induced exudation of alpha 2-macroglobulin into human nasal airways.
Greiff L; Andersson M; Svensson C; Persson CG
Clin Exp Allergy; 1997 Apr; 27(4):438-44. PubMed ID: 9146938
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitis.
Corren J; Storms W; Bernstein J; Berger W; Nayak A; Sacks H;
Clin Ther; 2005 May; 27(5):543-53. PubMed ID: 15978303
[TBL] [Abstract][Full Text] [Related]
9. Tolerability, pharmacokinetics and dose linearity of azelastine hydrochloride in healthy subjects.
Riethmüller-Winzen H; Peter G; Büker KM; Romeis P; Borbe HO
Arzneimittelforschung; 1994 Oct; 44(10):1136-40. PubMed ID: 7818588
[TBL] [Abstract][Full Text] [Related]
10. Anti-allergic properties of a new histamine antagonist, 4-(p-chlorobenzyl)-2- [N-methyl-perhydroazepinyl-(4)]-1-(2H)-phthalazinone hydrochloride (azelastine).
Tasaka K; Akagi M
Arzneimittelforschung; 1979; 29(3):488-93. PubMed ID: 90510
[TBL] [Abstract][Full Text] [Related]
11. [Effect of azelastine on bronchial hyperresponsiveness].
Iwata M; Nishiura T; Ishiguro H; Ikuta N; Tano M; Tsuji K; Matsuno T; Naito Y; Miyatake H
Arerugi; 1989 May; 38(5):428-33. PubMed ID: 2574028
[TBL] [Abstract][Full Text] [Related]
12. Dose-dependent protection by azelastine eye drops against pollen-induced allergic conjunctivitis. A double-blind, placebo-controlled study.
Horak F; Berger UE; Menapace R; Toth J; Stübner PU; Marks B
Arzneimittelforschung; 1998 Apr; 48(4):379-84. PubMed ID: 9608880
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of epinastine on bronchoconstriction induced by histamine, platelet activating factor and serotonin in guinea pigs and rats.
Tasaka K; Kamei C; Nakamura S
Arzneimittelforschung; 1994 Mar; 44(3):327-9. PubMed ID: 7910745
[TBL] [Abstract][Full Text] [Related]
14. Changes in aeroallergen-induced pulmonary mechanics in actively sensitized guinea pig: inhibition by azelastine.
Chand N; Nolan K; Sofia RD; Diamantis W
Ann Allergy; 1990 Feb; 64(2 Pt 1):151-4. PubMed ID: 1968325
[TBL] [Abstract][Full Text] [Related]
15. The in vivo potency and selectivity of azelastine as an H1 histamine-receptor antagonist in human airways and skin.
Rafferty P; Harrison PJ; Aurich R; Holgate ST
J Allergy Clin Immunol; 1988 Dec; 82(6):1113-8. PubMed ID: 2904931
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of azelastine nasal spray in patients with allergic rhinitis compared to placebo and budesonide.
Dorow P; Aurich R; Petzold U
Arzneimittelforschung; 1993 Aug; 43(8):909-12. PubMed ID: 8105785
[TBL] [Abstract][Full Text] [Related]
17. Effect of azelastine and ketotifen on the bronchial and skin responses to platelet-activating factor in humans.
Lai CK; Ollier S; Lau CK; Holgate ST
Clin Exp Allergy; 1991 Jul; 21(4):489-96. PubMed ID: 1680533
[TBL] [Abstract][Full Text] [Related]
18. Protective property of azelastine against histamine challenge of rhinal mucosa in domestic pigs.
Stroman F; Herold H; Szelenyi I
Arzneimittelforschung; 1991 Oct; 41(10):1092-4. PubMed ID: 1686828
[TBL] [Abstract][Full Text] [Related]
19. Azelastine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential.
McTavish D; Sorkin EM
Drugs; 1989 Nov; 38(5):778-800. PubMed ID: 2574665
[TBL] [Abstract][Full Text] [Related]
20. Effects of inhaled thiazinamium chloride on histamine-induced and exercise-induced bronchoconstriction.
Gong H; Brik A; Tashkin DP; Dauphinee B
Ann Allergy; 1989 Mar; 62(3):230-5. PubMed ID: 2564267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
